Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Inspire Medical Systems Inc (NYSE: INSP) closed the day trading at $176.33 up 3.73% from the previous closing price of $169.99. In other words, the price has increased by $3.73 from its previous closing price. On the day, 0.77 million shares were traded. INSP stock price reached its highest trading level at $177.53 during the session, while it also had its lowest trading level at $171.55.
Ratios:
For a better understanding of INSP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 138.33. For the most recent quarter (mrq), Quick Ratio is recorded 6.94 and its Current Ratio is at 7.84. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 20, 2024, Upgraded its rating to Buy and sets its target price to $255 from $220 previously.
On May 08, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $265 to $225.
On April 19, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $285.RBC Capital Mkts initiated its Outperform rating on April 19, 2024, with a $285 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 07 ’25 when Rondoni John sold 58 shares for $215.00 per share. The transaction valued at 12,470 led to the insider holds 11,322 shares of the business.
JOHN RONDONI bought 58 shares of INSP for $12,470 on Jan 07 ’25. On Nov 01 ’24, another insider, Rondoni John, who serves as the Chief Technology Officer of the company, sold 8,703 shares for $193.47 each. As a result, the insider received 1,683,731 and left with 11,348 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 5284063744 and an Enterprise Value of 4898405888. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 163.83, and their Forward P/E ratio for the next fiscal year is 90.56. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.99 while its Price-to-Book (P/B) ratio in mrq is 7.58. Its current Enterprise Value per Revenue stands at 6.483 whereas that against EBITDA is 266.435.
Stock Price History:
The Beta on a monthly basis for INSP is 1.33, which has changed by -0.12063527 over the last 52 weeks, in comparison to a change of 0.22212577 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $257.40, while it has fallen to a 52-week low of $123.00. The 50-Day Moving Average of the stock is -7.36%, while the 200-Day Moving Average is calculated to be -5.22%.
Shares Statistics:
Over the past 3-months, INSP traded about 530.34K shares per day on average, while over the past 10 days, INSP traded about 725370 shares per day. A total of 29.96M shares are outstanding, with a floating share count of 29.46M. Insiders hold about 1.70% of the company’s shares, while institutions hold 111.38% stake in the company. Shares short for INSP as of 1735603200 were 2369172 with a Short Ratio of 4.47, compared to 1732838400 on 1995770. Therefore, it implies a Short% of Shares Outstanding of 2369172 and a Short% of Float of 9.07.
Earnings Estimates
The current rating of Inspire Medical Systems Inc (INSP) is the result of assessments by 14.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.17, with high estimates of $0.04 and low estimates of -$0.34.
Analysts are recommending an EPS of between $1.4 and $1.2 for the fiscal current year, implying an average EPS of $1.32. EPS for the following year is $1.91, with 14.0 analysts recommending between $2.59 and $1.38.
Revenue Estimates
3 analysts predict $239.76M in revenue for the current quarter. It ranges from a high estimate of $240M to a low estimate of $239.6M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $192.51MFor the next quarter, 3 analysts are estimating revenue of $197.53M. There is a high estimate of $205M for the next quarter, whereas the lowest estimate is $191M.
A total of 7 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $803M, while the lowest revenue estimate was $796.43M, resulting in an average revenue estimate of $799.59M. In the same quarter a year ago, actual revenue was $624.8MBased on 17 analysts’ estimates, the company’s revenue will be $950.6M in the next fiscal year. The high estimate is $972M and the low estimate is $934.8M.
